QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
NASDAQ:CYAN

Cyanotech (CYAN) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.33
$0.33
50-Day Range
$2.83
$3.26
52-Week Range
$2.37
$6.29
Volume
1 shs
Average Volume
5,029 shs
Market Capitalization
$2.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CYAN stock logo

About Cyanotech Stock (NASDAQ:CYAN)

Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI.

CYAN Stock News Headlines

CYANOTECH CORP. DL-02 (JC7A)
The Next Nvidia?
The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.
One Cyanotech Insider Raised Stake By 42% In Previous Year
The Next Nvidia?
The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.
Hawaii aquaculture sales reach record high
Cyanotech Corp Q1 Loss Climbs
Q4 2023 Cyanotech Corp Earnings Call
Cyanotech GAAP EPS of -$0.55, revenue of $23.18M
The Global Sexual Enhancement Supplements Market
2023, Marine Bio Products Market Research | 2030
2023, Microalgae Market Research | 2030
See More Headlines
Receive CYAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyanotech and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/08/2024
Today
4/18/2024
Next Earnings (Estimated)
6/25/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
NASDAQ:CYAN
Employees
95
Year Founded
N/A

Profitability

Net Income
$-3,440,000.00
Pretax Margin
-20.48%

Debt

Sales & Book Value

Annual Sales
$23.18 million
Book Value
$2.61 per share

Miscellaneous

Free Float
5,196,000
Market Cap
$2.29 million
Optionable
Not Optionable
Beta
0.28
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

CYAN Stock Analysis - Frequently Asked Questions

When is Cyanotech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 25th 2024.
View our CYAN earnings forecast
.

How were Cyanotech's earnings last quarter?

Cyanotech Co. (NASDAQ:CYAN) issued its quarterly earnings results on Thursday, February, 8th. The biotechnology company reported ($0.16) earnings per share (EPS) for the quarter. The biotechnology company earned $5.58 million during the quarter. Cyanotech had a negative trailing twelve-month return on equity of 30.97% and a negative net margin of 20.52%.

What is Brent D. Bailey's approval rating as Cyanotech's CEO?

6 employees have rated Cyanotech Chief Executive Officer Brent D. Bailey on Glassdoor.com. Brent D. Bailey has an approval rating of 68% among the company's employees. 62.0% of employees surveyed would recommend working at Cyanotech to a friend.

What other stocks do shareholders of Cyanotech own?
This page (NASDAQ:CYAN) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners